The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma …
NJ Carr, F Bibeau, RF Bradley, P Dartigues… - …, 2017 - Wiley Online Library
The vermiform appendix is the primary site of several distinctive benign and malignant
neoplasms. Some can produce the clinical syndrome of pseudomyxoma peritonei (PMP). A …
neoplasms. Some can produce the clinical syndrome of pseudomyxoma peritonei (PMP). A …
G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
N Arang, JS Gutkind - FEBS letters, 2020 - Wiley Online Library
G protein‐coupled receptors (GPCRs) and heterotrimeric G proteins play central roles in a
diverse array of cellular processes. As such, dysregulation of GPCRs and their coupled …
diverse array of cellular processes. As such, dysregulation of GPCRs and their coupled …
Gαs–Protein kinase a (PKA) pathway signalopathies: the emerging genetic landscape and therapeutic potential of human diseases driven by aberrant Gαs-PKA …
Many of the fundamental concepts of signal transduction and kinase activity are attributed to
the discovery and crystallization of cAMP-dependent protein kinase, or protein kinase A …
the discovery and crystallization of cAMP-dependent protein kinase, or protein kinase A …
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
Background Mucinous ovarian tumors are an unusual group of rare neoplasms with an
apparently clear progression from benign to borderline to carcinoma, yet with a controversial …
apparently clear progression from benign to borderline to carcinoma, yet with a controversial …
An update on the diagnosis, grading, and staging of appendiceal mucinous neoplasms
MA Valasek, RK Pai - Advances in anatomic pathology, 2018 - journals.lww.com
Despite advances in our understanding of appendiceal mucinous neoplasms and their
relationship to the pseudomyxoma peritonei syndrome, the classification of mucinous tumors …
relationship to the pseudomyxoma peritonei syndrome, the classification of mucinous tumors …
Molecular classification of appendiceal adenocarcinoma
PURPOSE Appendiceal adenocarcinomas (ACs) are rare, histologically diverse
malignancies treated as colorectal cancers despite having distinct biology and clinical …
malignancies treated as colorectal cancers despite having distinct biology and clinical …
Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer
R Tokunaga, J Xiu, C Johnston, RM Goldberg… - Clinical Cancer …, 2019 - AACR
Purpose: The natural history and prognosis of appendiceal adenocarcinomas differ from
those of adenocarcinomas arising in other large bowel sites. We aimed to compare the …
those of adenocarcinomas arising in other large bowel sites. We aimed to compare the …
Current management of appendiceal neoplasms
RS Hoehn, CJ Rieser, MH Choudry… - American Society of …, 2021 - ascopubs.org
Appendiceal neoplasms include a heterogeneous group of epithelial and nonepithelial
tumors that exhibit varying malignant potential. This review article summarizes current …
tumors that exhibit varying malignant potential. This review article summarizes current …
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from …
NS Meagher, L Wang, PF Rambau, MP Intermaggio… - Modern …, 2019 - nature.com
Primary ovarian mucinous tumors can be difficult to distinguish from metastatic
gastrointestinal neoplasms by histology alone. The expected immunoprofile of a suspected …
gastrointestinal neoplasms by histology alone. The expected immunoprofile of a suspected …
Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin
H Alakus, ML Babicky, P Ghosh, S Yost, K Jepsen… - Genome medicine, 2014 - Springer
Background Mucinous neoplasms of the appendix (MNA) are rare tumors which may
progress from benign to malignant disease with an aggressive biological behavior. MNA is …
progress from benign to malignant disease with an aggressive biological behavior. MNA is …